Clinical Trial: Use of Methazolamide to Lower Intraocular Pressure

Study Status: RECRUITING
Recruit Status: RECRUITING
Study Type: INTERVENTIONAL

Official Title: Use of Methazolamide to Lower Intraocular Pressure

Brief Summary: The purpose of this study is to evaluate the effect of methazolamide, 25 mg or 50 mg tablets once a day for a week than twice a day for a week, on lowering intraocular pressure and the safety of methazolamide.

Detailed Summary:
Sponsor: University of Colorado, Denver

Current Primary Outcome: IOP measure is measured using Goldmann Tonometry.
IOP is measured in mmHg with a normal range from 12 mmHg to 22 mmHg.

Original Primary Outcome: IOP measure is measured using Goldmann Tonometry.
IOP is measured in mmHg with a normal range from 12 mmHg to 22 mmHg.

Current Secondary Outcome:

Original Secondary Outcome:

Information By: University of Colorado, Denver

Dates:
Date Received: August 09, 2022
Date Started: January 01, 2023
Date Completion: January 01, 2023
Last Updated: December 19, 2022
Last Verified: December 01, 2022